States See Looming Monoclonal Antibody Crunch as Biden Administration Rations Doses

Demand has increased 20-fold in recent weeks, expert says

A man enters the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Fla., on Aug. 19, 2021. Chandan Khanna/AFP via Getty Images

Some states are set to receive fewer doses of monoclonal antibody treatments after the Biden administration switched the distribution system this week.

Demand for monoclonal antibodies, used to treat non-hospitalized COVID-19 patients, has shot up in recent weeks, leading to what some officials have described as a shortage.